Morgan Stanley’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Morgan Stanley’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-470,146	Closed	-$47.3M	–	6915
2014 Q4	$47.3M	Sell	470,146 -159,611	-25%	-$12.4M	0.02%	894
2014 Q3	$41.8M	Buy	629,757 +112,462	+22%	+$7.39M	0.02%	919
2014 Q2	$36.1M	Sell	517,295 -33,049	-6%	-$2.25M	0.01%	988
2014 Q1	$40.3M	Buy	550,344 +34,523	+7%	+$2.57M	0.02%	874
2013 Q4	$35.5M	Sell	515,821 -120,927	-19%	-$7.83M	0.02%	934
2013 Q3	$40.5M	Buy	636,748 +123,324	+24%	+$7.45M	0.02%	781
2013 Q2	$24.8M	Buy	+513,424	New	+$25.2M	0.01%	1035

Morgan Stanley's CBST Position: Q1 2015 in Review

Morgan Stanley sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 470,146 shares — an estimated $47.3M sold.

Morgan Stanley first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $47.3M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Morgan Stanley reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Morgan Stanley sold 470,146 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $47.3M.
Morgan Stanley first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Morgan Stanley's CUBIST PHARMACEUTICALS INC position peaked at $47.3M in Q4 2014.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Morgan Stanley's 13F filing for Q1 2015, filed 14 May 2015.